Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...
Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...
In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...
Life has many ups and downs, and it's normal to feel the lows from time to time. However, for some people, this sadness may ...
About a third of them do not achieve adequate relief from traditional antidepressant medications and psychotherapy. The Pine ...
Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...
Neumora Therapeutics ( NMRA) shares crashed 80% to an all-time low Thursday when the biopharmaceutical firm announced that a ...
The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...
Ketamine, a hallucinogenic drug approved as an anesthetic, has been used to treat adults with depression, PTSD and other conditions, and studied in youth with depression.
In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant ...
After six weeks, both the treatment group and the placebo group experienced an average 12.5-point reduction on the Montgomery-Åsberg Depression Rating Scale (MADRS). The drug also fell short in i ...
Adults with attention-deficit/hyperactivity disorder (ADHD) who use an extended-release medication are more likely to ...